Subscribe Us

header ads

Recents

header ads

Augmented and Virtual Reality in Healthcare Market Size At Around US$ 19.6 Bn In 2030

 The augmented and virtual reality in healthcare market would grow at a CAGR of 26.88% over the predicted time frame. The market is expected to increase in value from US$ 2.92 Bn in 2022 to US$ 19.6 Bn in 2030.

Augmented and Virtual Reality in Healthcare Market Size 2022 To 2030

The on augmented and virtual reality in healthcare Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/2062

Report Scope of the Augmented and Virtual Reality in Healthcare Market

Report CoverageDetails
Market Size in 2022

USD 2.92 Billion

Market Size by 2030

USD 19.6 Billion

Growth Rate from 2022 to 2030CAGR of 26.88%
Base Year2021
Forecast Period2022 to 2030
Segments CoveredComponent, Technology, End User, Application and Geography
Companies Mentioned

Eon Reality, Inc, Layar, Bioflight VR, WorldViz, TheraSim Inc, CAE, GE Healthcare, Koninklijke Philips N.V., Intuitive Surgical, Siemens Ltd, Mindmaze

A recent report provides crucial insights along with application based and forecast information in the Global Augmented and virtual reality in healthcare Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Augmented and virtual reality in healthcare market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Augmented and virtual reality in healthcare market are included as given below:

Augmented and virtual reality in healthcare Market Key Players

  • Eon Reality, Inc
  • Layar
  • Bioflight VR
  • WorldViz
  • TheraSim Inc 
  • CAE
  • GE Healthcare
  • Koninklijke Philips N.V.
  • Intuitive Surgical
  • Siemens Ltd
  • Mindmaze

Market Segments

By Component

  • Hardware
    • Sensors
      • Accelerometer
      • Gyroscope
      • Magnetometer
      • Proximity Sensor 
    • Semiconductor Component
      • Controller/processor
      • Integrated Circuits
    • Displays and Projectors
    • Position Tracker
    • Cameras
    • Others
  • Software
  • Services

By Technology

  • Augmented Reality
    • Surgical Application
    • Rehabilitation
    • Training & Medical Education
  • Virtual Reality
    • Simulation
    • Diagnostics
    • Virtual Reality Exposure Therapy (VRET)
    • Rehabilitation
    • Pain Distraction

By End User

  • Hospitals, Clinics, and Surgical Centers
  • Research Organizations and Pharma Companies
  • Research and Diagnostics Laboratories
  • Government and Defense Institutions
  • Others

By Application

  • Surgery
  • Therapy
  • Education and training
  • Rehabilitation
  • Pain management
  • Others

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)

Report Objectives

  • To define, describe, and forecast the global augmented and virtual reality in healthcare market based on product, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
  • To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
  • To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the augmented and virtual reality in healthcare market

Table of Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Augmented and Virtual Reality in Healthcare Market 

5.1. COVID-19 Landscape: Augmented and Virtual Reality in Healthcare Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Augmented and Virtual Reality in Healthcare Market, By Component

8.1. Augmented and Virtual Reality in Healthcare Market, by Component, 2022-2030

8.1.1. Hardware

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Software

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Services

8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Augmented and Virtual Reality in Healthcare Market, By Technology

9.1. Augmented and Virtual Reality in Healthcare Market, by Technology e, 2022-2030

9.1.1. Augmented Reality

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Augmented Reality

9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Augmented and Virtual Reality in Healthcare Market, By End User 

10.1. Augmented and Virtual Reality in Healthcare Market, by End User, 2022-2030

10.1.1. Hospitals, Clinics, and Surgical Centers

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Research Organizations and Pharma Companies

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Research and Diagnostics Laboratories

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Government and Defense Institutions

10.1.4.1. Market Revenue and Forecast (2017-2030)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Augmented and Virtual Reality in Healthcare Market, By Application 

11.1. Augmented and Virtual Reality in Healthcare Market, by Application, 2022-2030

11.1.1. Surgery

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Therapy

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Education and training

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Rehabilitation

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Pain management

11.1.5.1. Market Revenue and Forecast (2017-2030)

11.1.5. Others

11.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Augmented and Virtual Reality in Healthcare Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Component (2017-2030)

12.1.2. Market Revenue and Forecast, by Technology (2017-2030)

12.1.3. Market Revenue and Forecast, by End User (2017-2030)

12.1.4. Market Revenue and Forecast, by Application (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Component (2017-2030)

12.1.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.1.5.3. Market Revenue and Forecast, by End User (2017-2030)

12.1.5.4. Market Revenue and Forecast, by Application (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Component (2017-2030)

12.1.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.1.6.3. Market Revenue and Forecast, by End User (2017-2030)

12.1.6.4. Market Revenue and Forecast, by Application (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Component (2017-2030)

12.2.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.3. Market Revenue and Forecast, by End User (2017-2030)

12.2.4. Market Revenue and Forecast, by Application (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Component (2017-2030)

12.2.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.5.3. Market Revenue and Forecast, by End User (2017-2030)

12.2.5.4. Market Revenue and Forecast, by Application (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Component (2017-2030)

12.2.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.6.3. Market Revenue and Forecast, by End User (2017-2030)

12.2.6.4. Market Revenue and Forecast, by Application (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Component (2017-2030)

12.2.7.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.7.3. Market Revenue and Forecast, by End User (2017-2030)

12.2.7.4. Market Revenue and Forecast, by Application (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Component (2017-2030)

12.2.8.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.8.3. Market Revenue and Forecast, by End User (2017-2030)

12.2.8.4. Market Revenue and Forecast, by Application (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Component (2017-2030)

12.3.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.3. Market Revenue and Forecast, by End User (2017-2030)

12.3.4. Market Revenue and Forecast, by Application (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Component (2017-2030)

12.3.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.5.3. Market Revenue and Forecast, by End User (2017-2030)

12.3.5.4. Market Revenue and Forecast, by Application (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Component (2017-2030)

12.3.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.6.3. Market Revenue and Forecast, by End User (2017-2030)

12.3.6.4. Market Revenue and Forecast, by Application (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Component (2017-2030)

12.3.7.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.7.3. Market Revenue and Forecast, by End User (2017-2030)

12.3.7.4. Market Revenue and Forecast, by Application (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Component (2017-2030)

12.3.8.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.8.3. Market Revenue and Forecast, by End User (2017-2030)

12.3.8.4. Market Revenue and Forecast, by Application (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Component (2017-2030)

12.4.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.3. Market Revenue and Forecast, by End User (2017-2030)

12.4.4. Market Revenue and Forecast, by Application (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Component (2017-2030)

12.4.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.5.3. Market Revenue and Forecast, by End User (2017-2030)

12.4.5.4. Market Revenue and Forecast, by Application (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Component (2017-2030)

12.4.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.6.3. Market Revenue and Forecast, by End User (2017-2030)

12.4.6.4. Market Revenue and Forecast, by Application (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Component (2017-2030)

12.4.7.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.7.3. Market Revenue and Forecast, by End User (2017-2030)

12.4.7.4. Market Revenue and Forecast, by Application (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Component (2017-2030)

12.4.8.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.8.3. Market Revenue and Forecast, by End User (2017-2030)

12.4.8.4. Market Revenue and Forecast, by Application (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Component (2017-2030)

12.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.5.3. Market Revenue and Forecast, by End User (2017-2030)

12.5.4. Market Revenue and Forecast, by Application (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Component (2017-2030)

12.5.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.5.5.3. Market Revenue and Forecast, by End User (2017-2030)

12.5.5.4. Market Revenue and Forecast, by Application (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Component (2017-2030)

12.5.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.5.6.3. Market Revenue and Forecast, by End User (2017-2030)

12.5.6.4. Market Revenue and Forecast, by Application (2017-2030)

Chapter 13. Company Profiles

13.1. Eon Reality, Inc

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Layar

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Bioflight VR

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. WorldViz

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. TheraSim Inc

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. CAE

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. GE Healthcare

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Koninklijke Philips N.V.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Intuitive Surgical

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Siemens Ltd

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

 

Post a Comment

0 Comments